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Introduction

Abstract: Rationale: In Pavlovian conditioning research,
nicotine is typically conceptualized as the unconditioned
stimulus (US) that becomes associated with an exteroceptive conditioned stimulus (CS). This research has not explored the possibility that nicotine can also function as a CS.
Objectives: The present research examined whether nicotine
served as a CS for the presence (CS+) or absence (CS–) of
sucrose and started defining its specificity. Methods and results: Rats trained in the CS+ condition had nicotine (0.4 mg/
kg, base) paired intermittently with brief access to sucrose.
Intermixed were saline sessions without sucrose. Nicotine
acquired the ability to evoke goal tracking. This conditioned
response (CR) decreased across extinction sessions. The CR
was sensitive to nicotine dose (ED50=0.113 mg/kg) and administration to testing interval; 0-min and 100-min delays
produced no CR. The CS properties were specific to nicotine
in that amphetamine and bupropion substitution was incomplete. Rats in the CS– condition received similar discrimination training except that sucrose was paired with saline.
Nicotine also served as a CS–; the saline state CS+ acquired
control of goal tracking. Mecamylamine, but not hexamethonium, blocked nicotine’s ability to serve as a CS+ and CS–,
indicating a role for central nicotinic acetylcholine receptors.
Conclusions: Nicotine served as a signal for the presence or
absence of sucrose. The extinction, CS–, and substitution results eliminated a psycho motor stimulant account. The conceptualization of nicotine as a CS suggests novel empirical
research in which a drug acquires additional inhibitory and/
or excitatory value based on other outcomes present during
its effects.

Nicotine is the primary addictive compound within tobacco products. Of particular interest in the present report is the
role that learned associative processes involving nicotine
might have in tobacco dependence (Carmody 1990; Rose
and Levin 1991; Henningfield et al. 1995, 1996; Lazev et al.
1999; Parrott 1999; Geier et al. 2000). Pavlovian (classical)
conditioning, one source of these learned drug associations,
typically consists of presenting a relatively neutral stimulus
(conditioned stimulus; CS) in close temporal proximity to a
more biologically relevant stimulus (unconditioned stimulus;
US). Conditioning is evidenced when responding to the CS
is modified relative to a control value (Pavlov 1927; Wasserman and Miller 1997). Translated for a typical smoker, the
US is presumably the widespread stimulus conditions produced by nicotine (Eikelboom and Stewart 1982). The CS
might include throat irritation, taste and odor of cigarettes,
or cigarette pack, as well as situational cues such as drinking at a nightclub (Rose and Levin 1991; Rose et al. 1993;
Pritchard et al. 1996; Geier et al. 2000).
Animal models have served to elucidate factors involved
in acquisition and expression of Pavlovian conditioned associations with nicotine. Such models include conditioned
taste avoidance, conditioned tolerance, place conditioning,
and locomotor conditioning (Table 1). As summarized in Table 1, associative models and—by extension—tobacco addiction theories place nicotine in the role of the US. For example, in the research by Walter and Kuschinsky (1989),
rats had a distinct environment (CS) repeatedly paired with
nicotine (US). Controls received similar exposure to the CS
and US in a temporally separated fashion. On the test day,
both sets of rats were exposed to the CS without nicotine.

Keywords: Amphetamine, Bupropion, Dopamine, Drug
discrimination, Nicotinic acetylcholine receptors, Smoking,
Tobacco
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Rats that had the context CS paired with nicotine displayed
an increase in activity, sniffing, and rearing relative to controls. These differences were taken as evidence that the environment CS entered into a learned association with the psycho motor effects of nicotine (Bevins et al. 2001).
Conceptualizing nicotine as a potent US has allowed for
important discoveries into basic mechanisms of nicotine dependence and contributed to advances in intervention strategies (e.g., extinction and counter-conditioning; see Rose
and Levin 1991). In contrast, the possibility that the pharmacological effects of nicotine might serve as a CS that acquires new excitatory properties [i.e., evoke a conditioned
response (CR)] has not been explored. This is not because
nicotine lacks cueing properties. The substantial operant
drug-discrimination literature leaves little doubt that the interoceptive effects of nicotine can guide reinforced responding. For example, the stimulus effects of nicotine can serve
as a cue in rats for responding on one of two levers in an operant conditioning chamber. That is, if pretreated with nicotine (0.4 mg/kg, base) then responding ten consecutive times
on the right lever (fixed ratio; FR10) is reinforced with food
delivery. In this situation, nicotine is referred to as a discriminative stimulus or SD. The opposite response-outcome relationship, left lever responding for food, is cued by administration of vehicle (Stolerman 1989).
Additionally, drug–drug conditioning research indicates
that one drug can serve as a cue for response-independent
delivery of another drug. For example, Revusky et al. (1989)
gave rats repeated exposure to pentobarbital (32 mg/kg) 30
min before d-amphetamine (24 mg/kg). Pentobarbital was
conceptualized as the CS and amphetamine as the US. Relative to drug-equated controls, the pentobarbital CS evoked
an increase in heart rate. A variant of this drug–drug conditioning preparation assumes that the early pharmacological effects of a drug serve as a CS for the subsequent and
typically more profound effects of the same drug (US). In
an early demonstration with rats, Greeley et al. (1984) found
that a low dose of ethanol (0.8 g/kg) reliably paired with a
later higher dose of ethanol (2.5 g/kg) came to control an in-
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crease in body temperature (i.e., a compensatory hyperthermic CR). For a more recent example, see the research of Siegel and colleagues with morphine (Kim et al. 1999).
In contrast to the drug–drug conditioning situation, we
were interested in associative processes involving a nondrug US (i.e., access to sucrose). To this end, we took advantage of a rat’s tendency to search in a location where appetitive outcomes have reliably occurred in the past (i.e., goal
tracking; Boakes 1977; Farwell and Ayres 1979). There were
two main reasons for selecting goal tracking. First, it is an
approach behavior directed to a discrete location (e.g., liquid
dipper or pellet cup). This feature allows for a clear operational definition of the CR that is reliably observed in many
laboratories despite differences in apparatus and protocols.
Second, there is a substantial literature showing the utility of
goal tracking for studying Pavlovian conditioning processes
using more typical CSs (Davey and Cleland 1982; Delamater 1995; Lattal and Nakajima 1998; Rescorla 1999; Bouton
and Sunsay 2003). With this in mind, the present research
examined the ability of the pharmacological effects of nicotine to serve as a CS+ (signal for intermittent access to sucrose) and CS– (signal the absence of the US). As detailed
below, we also investigated the specificity of the conditional
stimulus effects of nicotine.
Materials and methods
Animals
Male Sprague Dawley rats from Harlan (Indianapolis, IN) were
housed individually in plastic tubs lined with aspen shavings. Water was available in the home cage; access to food was restricted
such that each rat was kept at 85% of its free feeding weight (374
± 58 g). About every 30 days this 85% weight was increased by 2
g to accommodate a typical growth curve. The colony was maintained on a 12-h/12-h light/dark cycle, and all sessions occurred
in the light cycle. Experimental protocols were approved by the
University of Nebraska–Lincoln IACUC and followed the “Guide
for the Care and Use of Laboratory Animals” (National Research
Council, 1996).
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Apparatus

Group 1: extinction, reacquisition, and generalization

Seven operant conditioning chambers (ENV-018, Med Associates,
VT) measuring 30.5×24.1×21 cm (l×w×h) were used. Each chamber had aluminum sidewalls; the ceiling and front and back walls
were clear poly carbonate. On the bottom center of one sidewall
was a 5.2×5.2-cm (l×w) opening to a recessed dipper receptacle.
The dipper arm had a 0.1-ml cup that allowed delivery of a 32%
sucrose solution (w/v). An emitter/detector unit, located 1.2 cm
within the receptacle and 3 cm from the floor, was used to record
head entries. Each chamber was housed in a sound-attenuating cubicle that had a fan providing airflow and masking noise. A personal computer with Med Associates interface and software-timed
sessions recorded dipper entries and presented the sucrose.

Rats (n=7) began extinction training the day after the last acquisition session. During the 14 days of extinction, nicotine was administered as before, but sucrose was not presented. Reacquisition
training began the day after extinction. This training was identical to initial acquisition and continued for 20 days: ten nicotine
and ten saline sessions. Rats began generalization testing immediately following reacquisition. Generalization testing was conducted in 5-day cycles. Within a cycle, rats experienced two Nic+ and
two Sal– sessions in random order. Thus, it took two testing cycles
to use the eight programs from acquisition training. Day 5 of each
cycle was a 4-min test in which a rat was injected s.c. with its assigned nicotine dose (0.025, 0.05, 0.1, 0.2, 0.4, or 0.6 mg/ kg) 5
min before the session—no sucrose was delivered. A rat was only
tested if it met the criterion for that cycle (see Dependent measures). Rats that did not meet the criterion remained in the home
cage. Each rat was tested twice on each nicotine dose. That is,
once the rat completed its assigned testing order, testing on a new
randomly selected order began.

Drugs
(–)-Nicotine hydrogen tartrate, mecamylamine hydrochloride,
hexamethonium bromide, bupropion hydrochloride, and d-amphetamine sulfate (Sigma, St. Louis, MO) were dissolved in saline (1 mg/ml). Nicotine was brought to a pH of 7.0 ± 0.1 with a
dilute NaOH solution. Nicotine, hexamethonium, and mecamylamine were injected subcutaneously (s.c.); Amphetamine and bupropion were injected intraperitoneally (i.p.). All injections were
at a volume of 1 mg/ml. Nicotine doses are expressed as the base
form; all other drug doses are expressed as the salt form.
Nic+ groups (nicotine as a CS+)
Preliminary training
On the first day, rats were trained to access the sucrose solution
from anywhere in the chamber within 4 s. The cubicle door was
then closed and rats received a 25-min automated session in which
the probability of receiving 4-s access to sucrose in a 4-s interval was 0.1333 (two sucrose deliveries per minute). On the second
day, rats received a 50-min automated session in which the probability of receiving 4-s access to sucrose in a 4-s interval started at
0.1333 and was decreased across the session to 0.05 (three sucrose
deliveries per 4 min). The chamber was dark during dipper training and for all subsequent sessions.
Acquisition
For 40 consecutive days, rats (n=21) received nicotine (Nic+) and
saline (Sal–) sessions intermixed. Before each Nic+ session, rats
were injected s.c. with nicotine (0.4 mg/kg) 5 min before placement in the chamber. A session lasted 20 min and 32 s, during
which there were eight sucrose presentations (4 s each). To prevent rats from timing sucrose delivery, there were four nicotine
session programs that varied when sucrose was presented. The average interval between sucrose deliveries was 141 s (range 90–210
s); the average interval before the first sucrose delivery was 120 s
(range 90–150 s). Rats were injected s.c. with saline 5 min before
the start of a Sal– session. No sucrose was delivered in these sessions. However, four saline programs were generated that had 4s empty intervals that matched the nicotine programs for location
of sucrose deliveries making session length identical for Nic+ and
Sal– sessions. Each rat was given the four nicotine and four saline programs in random order without replacement in eight-session cycles with the restriction that no more than two of one program type occurred consecutively. After acquisition training, rats
were separated into three groups.

Group 2: injection to testing interval
The day following the final acquisition session, rats (n=7) began
the 5-day testing cycle described for group 1. On day 5 of each cycle was a temporal delay test in which rats were injected with the
training dose of nicotine, 0, 5, 25, or 50 min before placement in
the chambers for the 4-min test. At the 0-min delay, a rat was injected with nicotine and immediately placed in the chamber. Rats
were tested twice at each value.
Group 3: nAChR antagonism
Rats (n=7) assigned to this group began the 5-day testing cycles
the day after the final acquisition session. On the fifth day of the
cycle, each rat was pretreated s.c. with saline, the central and peripheral nicotinic acetylcholine receptor (nAChR) antagonist mecamylamine [(0.5 or 1.0 mg/kg); see Martin et al. 1989], or the peripheral nAChR antagonist hexamethonium [(2.5 mg/kg or 5.0
mg/kg); see Asghar and Roth 1971] 15 min before nicotine (i.e.,
20 min before start of the test session). Rats were tested twice at
each condition and nicotine (0.4 mg/kg) was administered 5 min
before placement in the chambers (cf. training).
Follow-up conditions
As a rat in group 1–3 completed its assigned test values, training
on the 5-day cycles continued. If the discrimination criterion was
met, then an amphetamine substitution test was conducted on the
fifth day to determine the specificity of the Pavlovian discrimination. For this substitution test, a rat was injected i.p. with saline
or its assigned dose of amphetamine (0.0625, 0.125, 0.25, 0.5, or
1.0 mg/ kg) and placed in the chamber 15 min later (Bevins et al.
1997). Rats (n=18) were tested once on each dose. A subset of rats
(n=8) that completed the amphetamine substitution tests continued
training and were tested on a dose of bupropion (10, 20, or 40 mg/
kg). This was of interest given its use as a pharmacotherapy (Zyban) and recent research showing its pharmacological effects substituted for a nicotine SD (Young and Glennon 2002). Not all rats
were tested on each dose (Table 2). Bupropion was injected i.p.
15 min before placement in the chambers (Munzar and Goldberg
2000). Following the bupropion test for some rats and the amphetamine test for other rats, an additional temporal delay test was conducted. This test was identical to the delay test described for group
2 except the values tested were 5 min and 100 min. Rats (n=11)
were tested once at each delay.
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sucrose delivery during training and was the duration for the testing criterion. Statistical significance was declared using a two-tailed rejection region of 0.05.

Nic-group (nicotine as a CS–)
Preliminary and acquisition training
Following dipper training, rats (n=7) began acquisition training
similar to that of the Nic+ groups (e.g., nicotine dose, injection protocol, programs, etc.) except that sucrose was delivered during saline sessions (Sal+) and not during nicotine sessions (Nic–). Acquisition training continued for 64 days [32 sessions of each type
(Sal+ and Nic–)].
nAChR antagonism
On the day following the final training session, rats began the 5-day
testing cycles as previously described. On the fifth day of each cycle, rats that met criterion were injected s.c. with an assigned solution (saline, 0.5 or 1.0 mg/kg mecamylamine, or 2.5 or 5.0 mg/
kg hexamethonium) 15 min before administration of nicotine. Rats
were tested twice with each solution.
Dependent measure, criterion, and data analyses
The main dependent measure was the number of dipper entries
per second before sucrose was delivered. A per second measure
was used because time between the beginning of the session and
the first sucrose delivery varied across sessions. Dipper entries before the first sucrose delivery were used to avoid including dipper entries induced by sucrose. To equate for time, the programs
used for sessions in which sucrose was not delivered (i.e., Sal– and
Nic–) included comparable 4-s intervals. This procedural maneuver provides a per second measure of dipper entries for analysis using identical intervals. To meet criterion in the 5-day testing cycles,
rats had to have more dipper entries per second during each sucrose
session relative to both non-reinforced sessions of that cycle. Omnibus tests were one-or two-way repeated-measures analysis of variance (ANOVA). Post-hoc comparisons used paired t-tests. When a
rat was tested twice on the same variable (e.g., drug dose or time
delay), a single value for analysis was obtained by taking an average of the two values for each rat. For all tests, the dipper entries per second were from the first 2 min of the test. We used the
first 2 min because it was comparable to the duration before first

Results
Nic+ groups
Acquisition. Figure 1 shows the results of the acquisition
phase for rats that were trained with nicotine as a CS+. Given that training was identical for all groups, the data were
pooled. The two-way, repeated-measures ANOVA revealed
a main effect of session (F19,380=1.781, P=0.023), of condition (Nic+ vs Sal–; F1,20=48.273, P<0.001), and a significant
session×condition interaction (F19,380=18.438, P<0.001). On
the first and second sessions, nicotine suppressed dipper entries (P values ≤ 0.007). As training continued, nicotine acquired control over goal tracking. From the sixth session on,
there were more dipper entries on Nic+ sessions than Sal–
sessions (values ≤ 0.024).

Group 1
Extinction. Figure 2A shows the results from the extinction
phase. For comparison, the solid line illustrates the average
dipper entries per second for the two saline sessions immediately before extinction; dashed lines represent the SEM.
There was a significant main effect of session(F13,78=6.994,
P<0.0001), indicating that dipper entries decreased across
sessions. To examine whether dipper entries returned to levels maintained in the absence of sucrose (complete extinction), goal tracking in each extinction session was compared
with saline. Goal tracking was significantly greater than that
maintained in the Sal– condition on extinction sessions 1–4,
and 9 (P values<0.05)
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Fig.3 Mean number of dipper entries per second ( ± 1 SEM) for
the first 2 min of the temporal delay tests for rats in group 2 (n=7).
The two right-most bars are from a separate follow-up test of the
administration to testing interval (n=11). Asterisks denote significant difference from the training delay (5 min; P<0.05).

Group 2

Fig.2 A Mean dipper entries per second ( ± 1 SEM) for
the first 2 min of each extinction session for rats in group 1
(n=7). The solid line represents the average of the first 2 min
for the three saline sessions before extinction. Dashed lines
represent the SEM. Asterisks denote significant difference
from the saline session average (P<0.05). B Average dipper
entries per second for the first 2 min of the nicotine generalization tests for the same rats after reacquisition training.
The solid line reflects the average of the first 2 min of the
two saline sessions that preceded testing on the 0.4mg/kg
dose. Dashed lines represent the SEM. The asterisk denotes
significant difference from the training dose of nicotine (0.4
mg/kg; P<0.05).
Nicotine generalization test. As a no-drug baseline, we calculated the average dipper entries per second for the first 2 min
of the two saline sessions that preceded testing on the training
dose (solid line in Fig. 2B). Because rats were tested twice on
each dose, we used the saline sessions before the first test of
the training dose (0.4 mg/ kg) for four rats; the value from the
second test was used for the remaining three rats. The oneway ANOVA revealed a significant effect of nicotine dose
(F5,30=8.654, P<0.0001). Post-hoc comparisons tested whether each dose was different from the training dose. Goal tracking was significantly lower at the 0.025-mg/kg dose of nicotine (P<0.05). There was a tendency for a difference at the
0.6-mg/kg dose (P=0.052). Using the linear portion of the
dose–effect curve (0.025–0.2 mg/kg), the median effective
dose (ED50) for the nicotine CS+ was 0.113 mg/kg.

Injection to testing interval. Changing the time of the nicotine injection before placement in the chamber significantly affected goal-tracking behavior (F4,24= 5.094, P=0.004;
left portion of Fig. 3). Specifically, nicotine administered
immediately before placement in the chamber significantly decreased dipper entries when compared with the 5-min
training delay. Continued goal-tracking at the 50-min delay
prompted the follow-up condition in which a 5-min and 100min delay were assessed (right-most bars of Fig. 3). Relative
to the 5-min delay, extending the delay to 100 min significantly reduced dipper entries (t10=5.026, P=0.0005).
Group 3
nAChR antagonism. Figure 4 shows the results from the
antagonism tests. For these tests, a separate repeated-measures ANOVA was conducted for each antagonist; saline
values were used for both ANOVAs. Hexamethonium pretreatment had no effect on dipper entries (F2,12=1.487).
In contrast, mecamylamine significantly reduced dipper
entries(F2,12=30.42, P<0.0001). Relative to saline, this reduction in goal tracking was evident at both mecamylamine
doses (P values <0.002), and suggests that the conditional
stimulus properties of nicotine are mediated by centrally located nAChRs.
Follow-up conditions
Amphetamine substitution. The results from the amphetamine substitution tests are shown in the top portion of Table 2. The overall ANOVA was significant
(F5,85=4.905, P=0.0005). Subsequent post-hoc tests compared each amphetamine dose with saline. The two highest amphetamine doses (0.5 mg/kg and 1.0 mg/kg) increased the number of dipper entries relative to saline
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Fig.4 The left-most set of bars reflect the mean number of
dipper entries per second ( ± 1 SEM) for the first 2 min of
the antagonism tests for rats in group 3 (n=7). Hexamethonium and mecamylamine were administered 20 min before the
start of the test (i.e., 15 min before nicotine). Asterisks denote significant difference from saline (P<0.05)
(P values<0.02). To determine whether this increase was
complete substitution for the nicotine CS, goal tracking
evoked by these two doses of amphetamine was compared
with goal tracking in the comparable time period of the nicotine training session that immediately preceded testing of
the 1.0-mg/kg amphetamine dose. Nicotine controlled significantly more goal tracking (0.163 ± 0.023 dipper entries
per second) than either amphetamine doses (0.5 and 1.0 mg/
kg; P values<0.0001).
Bupropion substitution. Given the identical injection protocols, each bupropion dose was compared with the saline data
collected during the amphetamine substitution phase. Not all
rats were tested on each bupropion dose, thus each paired ttest used saline data only from rats that were tested with the
bupropion dose being analyzed (lower portion of Table 2).
Only the 20-mg/kg dose bupropion increased dipper entries
relative to saline (t7 =2.847, P=0.025). The extent of goal
tracking to the 20-mg/kg bupropion dose was significantly
less than that seen in the first 2 min of the nicotine session
that preceded testing (0.094 ± 0.017 dipper entries per second; P=0.023).
Nic– group
Acquisition. Figure 5A shows the results of the acquisition
phase for rats that were trained with nicotine as a CS–. The
ANOVA revealed a main effect of condition (F1,6= 18.398,
P=0.005), of session (F31,186=1.644, P=0.024), and a significant session×condition interaction (F31,186= 1.822, P=0.008).
The variability in this group measure highlights two important
results. First, it suggests that only a subset of rats acquired
the discrimination by the end of this phase (Fig. 5B). Indeed,
four of the seven rats had all positive difference scores (saline
per second value minus nicotine value) in the last cycle of
this phase indicating consistently more dipper entries in Sal+

Fig.5 A Mean number of dipper entries per second ( ± 1 SEM) before the first delivery of sucrose during saline (Sal+) and nicotine
(Nic–) sessions for rats in the nicotine CS– condition. Asterisks denote significant difference (P<0.05) from the comparable nicotine
session. B Difference score for each rat during sessions 29 through
32. The open symbols represent rats with consistently positive difference scores. The filled symbols with dashed lines represent rats
that did not acquire the discrimination by the last cycle of the acquisition phase. C Mean dipper entries per second for the first 2
min of the antagonism tests. Hexamethonium and mecamylamine
were administered 20 min before the start of the test (i.e., 15 min
before nicotine). Asterisk denotes significant difference from saline
(P<0.05).

sessions. Second, the source of the variability was not in
withholding responding during nicotine CS– sessions. Rather, the variability was in the use of the non-drug state (operant chamber cues) as the cue for access to the US.
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nAChR antagonism
A separate ANOVA was conducted for each antagonist using
the same saline values. Pretreatment with mecamylamine
increased dipper entries(F2,12=8.106, P=0.006; Fig. 5C).
Relative to saline, this recovery of goal tracking with
mecamylamine (cf. Sal+) was significant only at the
1.0-mg/kg dose (P<0.018). In contrast, hexamethonium
pretreatment had no effect on dipper entries (F<1),
indicating that central nAChRs likely mediate the ability of
nicotine to serve as a CS–.
Discussion
In the early nicotine CS+ acquisition sessions, nicotine
suppressed dipper entries below the level seen in early
saline sessions. This suppression likely reflects motor ataxia
typically seen with higher nicotine doses (Stolerman et al.
1973; Bevins et al. 2001). This suppression dissipated across
sessions, and nicotine came to control more dipper entries
before first sucrose delivery than saline. We interpret this
pattern as reflecting tolerance to the locomotor suppressant
effects of nicotine (Stolerman et al. 1973; Clarke and Kumar
1983) and acquisition of an appetitive conditioned association
between nicotine and sucrose such that the nicotine CS evokes
goal tracking (Farwell and Ayres 1979).
Chronic exposure to nicotine induces locomotor
stimulation in rats (Clarke and Kumar 1983; Bevins et al.
2001). An alternative to this conditioning account suggests
that the activating effects of nicotine increase the rate of
dipper entries. The results from the extinction manipulation
do not support this stimulant account. That account predicts
no change in the level of dipper entries when the sucrose US
is withheld in the extinction phase because nicotine was still
present to activate dipper entries. This did not occur. Rather,
nicotine-evoked goal tracking decreased systematically across
repeated extinction sessions. This sensitivity to removal
of the US is an important feature of Pavlovian conditioned
associations (Pavlov 1927; Wasserman and Miller 1997) and
suggests that the pharmacological effects of nicotine entered
into an excitatory association with sucrose.
A variant of the stimulant account suggests that availability
of sucrose during acquisition alters the probability of
particular behaviors. For example, the chamber for each rat
was paired with sucrose 50% of the time. Perhaps intermittent
pairings make the exteroceptive cues that compose the
chamber mildly excitatory. This weak conditioned excitation
might be enhanced by a psycho motor stimulant with
appetitive properties such as nicotine. The extinction phase
changed the probability of chamber-sucrose pairings to 0.
This non-reinforcement would have a cumulative effect on
the frequency of different behaviors including dipper entries.
This modified stimulant account predicts that administration
of another psycho motor stimulant with appetitive effects
should similarly increase dipper entries as long as the

chamber cues were not extinguished. This did not occur.
Amphetamine (0.5 mg/kg and 1 mg/kg) did not even increase dipper entries to half that controlled by nicotine
even though these doses of amphetamine readily stimulate a wide range of behaviors (Garrett and Holtzman
1996; Antoniou et al. 1998; Badiani et al. 2000). Indeed,
in our laboratory, these doses of amphetamine are more
potent at activating locomotor behavior than nicotine
(Palmatier et al. 2003).
In two ways, a conditioning interpretation is further
supported by the finding that nicotine can serve as a signal for the absence of sucrose (CS–). First, there is a substantial Pavlovian conditioning literature showing that
exteroceptive stimuli can readily signal the absence of an
US (Pavlov 1927; Bouton and Brooks 1993; Tinsley et
al. 2002). The present results suggest that nicotine also
has this ability to function as a CS–. An interesting possibility is that the nicotine CS– has become a conditioned
inhibitor. Procedurally it is plausible because the nicotine cue occurs in the presence of an excitatory cue (i.e.,
the chamber). However, establishing whether the nicotine
CS– has acquired inhibitory properties will require additional research using specifically developed procedures
(Pavlov 1927; Rescorla 1969; Wasserman at al. 1974).
Second, nicotine’s ability to function as a CS– is inconsistent with either variant of the stimulant account of the
CS+ data. That is, appetitive food-seeking behaviors were
readily withheld during the nicotine CS–, a result more
consistent with a conditioning interpretation.
Conditional control of goal tracking was dose dependent. From a conditioning perspective, this result is important because it demonstrates that changes in the salience of
the training CS result in alterations in the CR. Similar results have been reported in a wide range of Pavlovian conditioning preparations (Rohrbaugh et al. 1971; Scavio and
Gormezano 1974; Brennan 1975; Czaplicki et al. 1976).
The ability to generate an orderly dose–effect function
suggests that this preparation might be utilized to study
the neuropharmacological processes mediatingthe ability
of a drug to serve as a CS in much the same fashion that
drug discrimination is used to study processes mediating
a drug’s ability to serve as a SD. The generalization function described for the nicotine CS+ is similar to that reported in the drug-discrimination literature (Chance et al.
1977; Pratt et al. 1983; Stolerman et al. 1984; Shoaib et al.
1997). Also, the ED50 for the conditional stimulus effects
of nicotine using goal tracking (0.113 mg/kg) was in the
same range as previous drug-discrimination research using
lever pressing [e.g., Chance et al. 1977 (ED50 =0.087 mg/
kg); Pratt et al. 1983 (ED50 =0.14 mg/kg)].
Nicotine’s ability to serve as a CS+ or CS– appears to
be mediated by centrally located nAChRs. For the CS+,
goal tracking was blocked by pretreatment with mecamylamine (0.5 mg/kg and 1 mg/kg) but not by hexamethonium. Similar results have been reported for the discriminative stimulus effects of nicotine (Morrison and
Stephenson 1969; Stolerman et al. 1984). For the nicotine CS–, goal tracking increased to saline levels (i.e., the
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CS+) with pretreatment of mecamylamine (1 mg/kg), but not
hexamethonium. This latter result is notable because antagonism is evidenced as an increase in dipper entries. This feature eliminates any motor impairment account of mecamylamine blockade of goal tracking to the nicotine CS+.
The nature of the nicotine CS+ varied with time since administration. Goal tracking was significantly reduced when
nicotine was injected immediately or 100 min before testing. Given that CS-elicited goal tracking is mediated by central nAChRs, this time-dependent data pattern is likely due
to changes in brain concentrations of nicotine. For example,
Ghosheh et al. (1999) measured brain concentrations of nicotine in rats at different time points after a s.c. injection of
0.8 mg/kg nicotine (base). Ghosheh et al.’s (1999) temporal-effect curve for brain levels of nicotine nicely parallels
our temporal-effect function for goal tracking with concentrations of nicotine peaking at 5 min after the injection and,
thereafter, declined resulting in a half-life of 52 min. Thus,
the loss of goal tracking at the 100-min interval likely reflects a significant decrease in brain levels of nicotine. A reduction in goal tracking when the nicotine CS+ was administered immediately before the test suggests that the brain
concentration of nicotine had not reached sufficient levels
(Pratt et al. 1983). Similar temporal-effect functions have
been reported in the operant drug-discrimination literature
(Hirschhorn and Rosecrans 1974; Chance et al. 1977; Pratt
et al. 1983; Schechter and Meehan 1992).
The ability of nicotine to serve as a CS+ was not based on
a drug versus no-drug discrimination. If this had occurred,
amphetamine and bupropion would have fully substituted for
the nicotine CS. Instead, amphetamine and bupropion only
partially substituted for nicotine indicating stimulus-specific
control of goal tracking by nicotine. Incomplete substitution
by amphetamine further suggests that the appetitive discrimination was not based on dopaminergic processes or stimulant properties shared by nicotine and amphetamine. This
outcome and conclusion is consistent with the operant drugdiscrimination literature. That research, using different training and testing procedures consistently reports an inability
of amphetamine to completely substitute for a nicotine SD
(Morrison and Stephenson 1969; Schechter and Rosecrans
1972; Stolerman et al. 1984; Mansbach et al. 1998).
Bupropion substitution for the nicotine CS+ was also incomplete suggesting that any similar effect by nicotine and
bupriopion on dopamine-containing neurons (Ferris et al.
1983; Ascher et al. 1995; Seppä and Ahtee 2000; Yin and
French 2000), at least alone, is not responsible for nicotine’s ability to serve as a CS+. The operant drug-discrimination literature is mixed on bupropion substitution for nicotine (full substitution: Wiley et al. 2002; Young and Glennon
2002; no substitution: Shoaib et al. 2003). Further research
will be required to determine the procedural details that affect bupropion’s ability to evoke nicotine-like responding in
both preparations.
One might suggest that differential control of goal
tracking reflects state-dependent learning (Overton 1964;
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Cunningham 1979). With the nicotine CS+ procedure, this
would mean that goal tracking is controlled by the chamber cues. However, this chamber-sucrose association is more
readily recalled under the effects of nicotine. For the CS–
condition, nicotine decreases recall of the chamber-sucrose
association learned in a saline state. To our knowledge, the
only repeatable demonstration of state-dependent learning
with nicotine uses human smokers and recall of word lists
(Peters and McGee 1982; Warburton et al. 1986). Like other
tasks using abstaining smokers, it is unclear whether effects
are attributable to nicotine withdrawal or state dependency. This, and the fact that there have been numerous demonstrations that nicotine typically enhances performance on a
learned task even when nicotine is not administered during
testing (Levin and Simon 1998), decreases our enthusiasm
for a state-dependency account.
In the present research, sucrose was delivered independent of the rat’s behavior. From a procedural perspective,
this is a Pavlovian procedure in which a stimulus (nicotine)
is reliably paired with another stimulus (sucrose). According
to this perspective, nicotine has acquired appetitive-motivational value. Because rats have evolutionarily pre-disposed
approach tendencies to stimuli that have appetitive qualities
(Bolles 1970; Ikemoto and Panksepp 1999), stimuli associated with these appetitive effects also come to control approach behaviors (i.e., goal tracking). Notably, the rat must
insert its head into the recessed dipper to access the sucrose.
Thus, embedded within the experimental protocol is a response-outcome relationship. If one views the adventitious
reinforcement of dipper entries as the controlling variable,
then nicotine may be conceptualized as an SD.The present
research was not designed to assess the relative contribution
of stimulus-outcome and response-outcome contingencies.
However, research that has tried with discrete exteroceptive
stimuli has been mixed suggesting that both contingencies
might be important (Boakes 1977; Farwell and Ayres 1979).
For now, we prefer to use the descriptive and theoretical language provided by the Pavlovian conditioning perspective if
for no other reason than it suggests novel empirical research
in which drugs serve as CSs acquiring inhibitory and/or excitatory value.
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